{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:06:04Z","timestamp":1794024364619,"version":"4.8.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011495","name":"Massachusetts Life Sciences Center","doi-asserted-by":"publisher","award":["6945983, 6947253, 6946296"],"award-info":[{"award-number":["6945983, 6947253, 6946296"]}],"id":[{"id":"10.13039\/100011495","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68031-6","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:03:20Z","timestamp":1770113000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A vascularized liver microphysiological system captures key features of hepatic insulin resistance and monocyte infiltration"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7645-1957","authenticated-orcid":false,"given":"Erin N.","family":"Tevonian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3125-2492","authenticated-orcid":false,"given":"Ellen L.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-5017","authenticated-orcid":false,"given":"Kairav K.","family":"Maniar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-304X","authenticated-orcid":false,"given":"Roger D.","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-989X","authenticated-orcid":false,"given":"Douglas A.","family":"Lauffenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-5548","authenticated-orcid":false,"given":"Linda G.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"68031_CR1","doi-asserted-by":"crossref","unstructured":"Nagy, P., Thorgeirsson, S. S. & Grisham, J. W. Organizational Principles of the Liver. in The Liver: Biology and Pathobiology 1\u201313 (John Wiley & Sons, Ltd, Chichester, UK, 2020).","DOI":"10.1002\/9781119436812.ch1"},{"key":"68031_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson, M. W., Harmon, C. & O\u2019Farrelly, C. Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 13, 267\u2013276 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"68031_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2021.03.007","volume":"33","author":"GF Lewis","year":"2021","unstructured":"Lewis, G. F., Carpentier, A. C., Pereira, S., Hahn, M. & Giacca, A. Direct and indirect control of hepatic glucose production by insulin. Cell Metab. 33, 709\u2013720 (2021).","journal-title":"Cell Metab."},{"key":"68031_CR4","doi-asserted-by":"crossref","unstructured":"Fujii, H., Kawada, N. & Japan Study Group of NAFLD (JSG-NAFLD). The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int. J. Mol. Sci. 21, E3863 (2020).","DOI":"10.3390\/ijms21113863"},{"key":"68031_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2337\/dsi23-0013","volume":"37","author":"JP Nogueira","year":"2024","unstructured":"Nogueira, J. P. & Cusi, K. Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care. Diab. Spectr. 37, 20\u201328 (2024).","journal-title":"Diab. Spectr."},{"key":"68031_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","volume":"36","author":"T Bo","year":"2024","unstructured":"Bo, T. et al. Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. Cell Metab. 36, 947\u2013968 (2024).","journal-title":"Cell Metab."},{"key":"68031_CR7","first-page":"198","volume":"34","author":"SM Najjar","year":"2019","unstructured":"Najjar, S. M. & Perdomo, G. Hepatic insulin clearance: mechanism and physiology. Physiol. Bethesda Md 34, 198\u2013215 (2019).","journal-title":"Physiol. Bethesda Md"},{"key":"68031_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/joim.12483","volume":"280","author":"J Jager","year":"2016","unstructured":"Jager, J., Aparicio-Vergara, M. & Aouadi, M. Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells. J. Intern. Med. 280, 209\u2013220 (2016).","journal-title":"J. Intern. Med."},{"key":"68031_CR9","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.7150\/ijbs.47143","volume":"16","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Kupffer cells in non-alcoholic fatty liver disease: friend or foe?. Int. J. Biol. Sci. 16, 2367\u20132378 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"68031_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/10408444.2012.682115","volume":"42","author":"EL LeCluyse","year":"2012","unstructured":"LeCluyse, E. L., Witek, R. P., Andersen, M. E. & Powers, M. J. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit. Rev. Toxicol. 42, 501\u2013548 (2012).","journal-title":"Crit. Rev. Toxicol."},{"key":"68031_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","volume":"6","author":"M Vacca","year":"2024","unstructured":"Vacca, M. et al. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nat. Metab. 6, 1178\u20131196 (2024).","journal-title":"Nat. Metab."},{"key":"68031_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"68031_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.addr.2014.02.011","volume":"69\u201370","author":"MR Ebrahimkhani","year":"2014","unstructured":"Ebrahimkhani, M. R., Neiman, J. A. S., Raredon, M. S. B., Hughes, D. J. & Griffith, L. G. Bioreactor technologies to support liver function in vitro. Adv. Drug Deliv. Rev. 69\u201370, 132\u2013157 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"68031_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1039\/B913221J","volume":"10","author":"K Domansky","year":"2010","unstructured":"Domansky, K. et al. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 10, 51\u201358 (2010).","journal-title":"Lab Chip"},{"key":"68031_CR15","doi-asserted-by":"publisher","first-page":"045024","DOI":"10.1088\/1758-5090\/ac23aa","volume":"13","author":"P Sphabmixay","year":"2021","unstructured":"Sphabmixay, P. et al. High resolution stereolithography fabrication of perfusable scaffolds to enable long-term meso-scale hepatic culture for disease modeling. Biofabrication 13, 045024 (2021).","journal-title":"Biofabrication"},{"key":"68031_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1124\/jpet.116.237495","volume":"360","author":"N Tsamandouras","year":"2017","unstructured":"Tsamandouras, N. et al. Quantitative assessment of population variability in hepatic drug metabolism using a perfused three-dimensional human liver microphysiological system. J. Pharmacol. Exp. Ther. 360, 95\u2013105 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"68031_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch. Toxicol. 87, 1315\u20131530 (2013).","journal-title":"Arch. Toxicol."},{"key":"68031_CR18","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts, E., Gannon, M. & Wasserman, D. H. The liver. Curr. Biol. 27, R1147\u2013R1151 (2017).","journal-title":"Curr. Biol."},{"key":"68031_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","volume":"15","author":"S Shetty","year":"2018","unstructured":"Shetty, S., Lalor, P. F. & Adams, D. H. Liver sinusoidal endothelial cells\u2014gatekeepers of hepatic immunity. Nat. Rev. Gastroenterol. Hepatol. 15, 555\u2013567 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"68031_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40883-018-0046-2","volume":"4","author":"AZ Unal","year":"2018","unstructured":"Unal, A. Z., Jeffs, S. E. & West, J. L. 3D co-culture with vascular cells supports long-term hepatocyte phenotype and function in vitro. Regen. Eng. Transl. Med. 4, 21\u201334 (2018).","journal-title":"Regen. Eng. Transl. Med."},{"key":"68031_CR21","doi-asserted-by":"crossref","unstructured":"Wesseler, M. F. et al. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation. Acta Biomater. 171, 336\u2013339 (2023).","DOI":"10.1016\/j.actbio.2023.09.022"},{"key":"68031_CR22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1021\/bm401926k","volume":"15","author":"Y Liu","year":"2014","unstructured":"Liu, Y., Li, H., Yan, S., Wei, J. & Li, X. Hepatocyte cocultures with endothelial cells and fibroblasts on micropatterned fibrous mats to promote liver-specific functions and capillary formation capabilities. Biomacromolecules 15, 1044\u20131054 (2014).","journal-title":"Biomacromolecules"},{"key":"68031_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122731","volume":"312","author":"HT Nguyen","year":"2025","unstructured":"Nguyen, H. T. et al. Patient-specific vascularized tumor model: Blocking monocyte recruitment with multispecific antibodies targeting CCR2 and CSF-1R. Biomaterials 312, 122731 (2025).","journal-title":"Biomaterials"},{"key":"68031_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.biomaterials.2018.03.005","volume":"198","author":"A Boussommier-Calleja","year":"2019","unstructured":"Boussommier-Calleja, A. et al. The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model. Biomaterials 198, 180\u2013193 (2019).","journal-title":"Biomaterials"},{"key":"68031_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33114-1","volume":"13","author":"S Sun","year":"2022","unstructured":"Sun, S., Jin, L., Zheng, Y. & Zhu, J. Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform. Nat. Commun. 13, 5481 (2022).","journal-title":"Nat. Commun."},{"key":"68031_CR26","doi-asserted-by":"publisher","first-page":"733317","DOI":"10.3389\/fimmu.2021.733317","volume":"12","author":"J Song","year":"2021","unstructured":"Song, J. et al. High-throughput 3D in vitro tumor vasculature model for real-time monitoring of immune cell infiltration and cytotoxicity. Front. Immunol. 12, 733317 (2021).","journal-title":"Front. Immunol."},{"key":"68031_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115867119","volume":"119","author":"A Chhabra","year":"2022","unstructured":"Chhabra, A. et al. A vascularized model of the human liver mimics regenerative responses. Proc. Natl. Acad. Sci. 119, e2115867119 (2022).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"68031_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10456-022-09842-9","volume":"25","author":"F Bonanini","year":"2022","unstructured":"Bonanini, F. et al. In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed. Angiogenesis 25, 455\u2013470 (2022).","journal-title":"Angiogenesis"},{"key":"68031_CR29","doi-asserted-by":"publisher","first-page":"064108","DOI":"10.1063\/5.0172677","volume":"17","author":"E Wang","year":"2023","unstructured":"Wang, E., Andrade, M. J. & Smith, Q. Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction. Biomicrofluidics 17, 064108 (2023).","journal-title":"Biomicrofluidics"},{"key":"68031_CR30","doi-asserted-by":"publisher","first-page":"015007","DOI":"10.1088\/1758-5090\/ad818a","volume":"17","author":"F Bonanini","year":"2025","unstructured":"Bonanini, F. et al. A microvascularized in vitro liver model for disease modeling and drug discovery. Biofabrication 17, 015007 (2025).","journal-title":"Biofabrication"},{"key":"68031_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32722-6","volume":"8","author":"M Kozyra","year":"2018","unstructured":"Kozyra, M. et al. Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Sci. Rep. 8, 14297 (2018).","journal-title":"Sci. Rep."},{"key":"68031_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep4.1450","volume":"4","author":"T Kostrzewski","year":"2020","unstructured":"Kostrzewski, T. et al. A Microphysiological System for Studying Nonalcoholic Steatohepatitis. Hepatol. Commun. 4, 77\u201391 (2020).","journal-title":"Hepatol. Commun."},{"key":"68031_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14815-w","volume":"7","author":"S Bauer","year":"2017","unstructured":"Bauer, S. et al. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Sci. Rep. 7, 14620 (2017).","journal-title":"Sci. Rep."},{"key":"68031_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14218\/JCTH.2020.00015","volume":"8","author":"M Duriez","year":"2020","unstructured":"Duriez, M. et al. A 3D Human Liver Model of Nonalcoholic Steatohepatitis. J. Clin. Transl. Hepatol. 8, 1\u201312 (2020).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"68031_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90954","volume":"1","author":"RE Feaver","year":"2016","unstructured":"Feaver, R. E. et al. Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight 1, e90954 (2016).","journal-title":"JCI Insight"},{"key":"68031_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","volume":"18","author":"J Gracia-Sancho","year":"2021","unstructured":"Gracia-Sancho, J., Caparr\u00f3s, E., Fern\u00e1ndez-Iglesias, A. & Franc\u00e9s, R. Role of liver sinusoidal endothelial cells in liver diseases. Nat. Rev. Gastroenterol. Hepatol. 18, 411\u2013431 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"68031_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/918267","volume":"2012","author":"GK Kolluru","year":"2012","unstructured":"Kolluru, G. K., Bir, S. C. & Kevil, C. G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int. J. Vasc. Med. 2012, 1\u201330 (2012).","journal-title":"Int. J. Vasc. Med."},{"key":"68031_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","volume":"53","author":"S Tran","year":"2020","unstructured":"Tran, S. et al. Impaired kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity 53, 627\u2013640.e5 (2020).","journal-title":"Immunity"},{"key":"68031_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov, K. et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 145\u2013159 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"68031_CR40","doi-asserted-by":"crossref","unstructured":"Wang, A. J. et al. Engineering modular 3D liver culture microenvironments in vitro to parse the interplay between biophysical and biochemical microenvironment cues on hepatic phenotypes. Adv. NanoBiomed Res. 2, 2100049 (2022).","DOI":"10.1002\/anbr.202100049"},{"key":"68031_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1039\/C2LC40787F","volume":"13","author":"Y-H Hsu","year":"2013","unstructured":"Hsu, Y.-H. et al. Full range physiological mass transport control in 3D tissue cultures. Lab Chip 13, 81\u201389 (2013).","journal-title":"Lab Chip"},{"key":"68031_CR42","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1039\/c3lc41320a","volume":"13","author":"S Kim","year":"2013","unstructured":"Kim, S., Lee, H., Chung, M. & Jeon, N. L. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab. Chip 13, 1489 (2013).","journal-title":"Lab. Chip"},{"key":"68031_CR43","doi-asserted-by":"publisher","first-page":"2002444","DOI":"10.1002\/adfm.202002444","volume":"30","author":"K Haase","year":"2020","unstructured":"Haase, K., Offeddu, G. S., Gillrie, M. R. & Kamm, R. D. Endothelial regulation of drug transport in a 3D vascularized tumor model. Adv. Funct. Mater. 30, 2002444 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"68031_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41596-021-00635-w","volume":"17","author":"C Hajal","year":"2022","unstructured":"Hajal, C. et al. Engineered human blood\u2013brain barrier microfluidic model for vascular permeability analyses. Nat. Protoc. 17, 95\u2013128 (2022).","journal-title":"Nat. Protoc."},{"key":"68031_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201902393","volume":"15","author":"GS Offeddu","year":"2019","unstructured":"Offeddu, G. S. et al. Application of transmural flow across in vitro microvasculature enables direct sampling of interstitial therapeutic molecule distribution. Small 15, 1902393 (2019).","journal-title":"Small"},{"key":"68031_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.biomaterials.2019.05.022","volume":"212","author":"GS Offeddu","year":"2019","unstructured":"Offeddu, G. S. et al. An on-chip model of protein paracellular and transcellular permeability in the microcirculation. Biomaterials 212, 115\u2013125 (2019).","journal-title":"Biomaterials"},{"key":"68031_CR47","doi-asserted-by":"publisher","unstructured":"Hellen, D. J. et al. A Microphysiological Model of Progressive Human Hepatic Insulin Resistance. Commun. Biol.. Preprint at https:\/\/doi.org\/10.1101\/2025.01.08.631261 (2025). in press.","DOI":"10.1101\/2025.01.08.631261"},{"key":"68031_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1039\/C9LC00768G","volume":"20","author":"AR Baudy","year":"2020","unstructured":"Baudy, A. R. et al. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab. Chip 20, 215\u2013225 (2020).","journal-title":"Lab. Chip"},{"key":"68031_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3727\/096368910X516655","volume":"20","author":"DN Khuu","year":"2011","unstructured":"Khuu, D. N. et al. In vitro differentiated adult human liver progenitor cells display mature hepatic metabolic functions: a potential tool for in vitro pharmacotoxicological testing. Cell Transpl. 20, 287\u2013302 (2011).","journal-title":"Cell Transpl."},{"key":"68031_CR50","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/term.3042","volume":"14","author":"J Wei","year":"2020","unstructured":"Wei, J. et al. Glucose and lipid metabolism screening models of hepatocyte spheroids after culture with injectable fiber fragments. J. Tissue Eng. Regen. Med. 14, 774\u2013788 (2020).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"68031_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-018-0062-7","volume":"3","author":"H Zou","year":"2018","unstructured":"Zou, H. et al. Chemical genetic-based phenotypic screen reveals novel regulators of gluconeogenesis in human primary hepatocytes. Npj Genom. Med 3, 20 (2018).","journal-title":"Npj Genom. Med"},{"key":"68031_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/nu9040387","volume":"9","author":"H Kitade","year":"2017","unstructured":"Kitade, H., Chen, G., Ni, Y. & Ota, T. Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments. Nutrients 9, 387 (2017).","journal-title":"Nutrients"},{"key":"68031_CR53","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.29544","volume":"67","author":"O Krenkel","year":"2018","unstructured":"Krenkel, O. et al. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 67, 1270\u20131283 (2018).","journal-title":"Hepatology"},{"key":"68031_CR54","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","volume":"291","author":"JB Meigs","year":"2004","unstructured":"Meigs, J. B. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291, 1978 (2004).","journal-title":"JAMA"},{"key":"68031_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2362.2002.00919.x","volume":"32","author":"A Becker","year":"2002","unstructured":"Becker, A. et al. Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality?. Eur. J. Clin. Invest. 32, 1\u20138 (2002).","journal-title":"Eur. J. Clin. Invest."},{"key":"68031_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12618","volume":"27","author":"BA Corliss","year":"2020","unstructured":"Corliss, B. A. et al. REAVER: a program for improved analysis of high-resolution vascular network images. Microcirculation 27, e12618 (2020).","journal-title":"Microcirculation"},{"key":"68031_CR57","doi-asserted-by":"publisher","first-page":"14635","DOI":"10.1074\/jbc.M608565200","volume":"282","author":"AS Morss","year":"2007","unstructured":"Morss, A. S. & Edelman, E. R. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J. Biol. Chem. 282, 14635\u201314644 (2007).","journal-title":"J. Biol. Chem."},{"key":"68031_CR58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13098-015-0098-0","volume":"7","author":"X-Y Zhao","year":"2015","unstructured":"Zhao, X.-Y. et al. Effects of high glucose on human umbilical vein endothelial cell permeability and myosin light chain phosphorylation. Diabetol. Metab. Syndr. 7, 98 (2015).","journal-title":"Diabetol. Metab. Syndr."},{"key":"68031_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/10739680701283091","volume":"14","author":"SY Yuan","year":"2007","unstructured":"Yuan, S. Y. et al. Microvascular permeability in diabetes and insulin resistance. Microcirculation 14, 363\u2013373 (2007).","journal-title":"Microcirculation"},{"key":"68031_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4239\/wjd.v10.i2.63","volume":"10","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany, M. M., Ameneiros-Rodr\u00edguez, E., Fern\u00e1ndez-Fern\u00e1ndez, C., Dom\u00ednguez-Montero, A. & Funcasta-Calder\u00f3n, R. Insulin resistance is associated with subclinical vascular disease in humans. World J. Diab. 10, 63\u201377 (2019).","journal-title":"World J. Diab."},{"key":"68031_CR61","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s00125-012-2533-1","volume":"55","author":"T Parkner","year":"2012","unstructured":"Parkner, T. et al. Soluble CD163: a biomarker linking macrophages and insulin resistance. Diabetologia 55, 1856\u20131862 (2012).","journal-title":"Diabetologia"},{"key":"68031_CR62","doi-asserted-by":"crossref","unstructured":"Kazankov, K., Bojsen-M\u00f8ller, K. N., M\u00f8ller, H. J., Madsbad, S. & Gr\u00f8nb\u00e6k, H. Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass. Physiol. Rep. 10, e15157 (2022).","DOI":"10.14814\/phy2.15157"},{"key":"68031_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01720-9","volume":"22","author":"Q He","year":"2024","unstructured":"He, Q. et al. Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease. Cell Commun. Signal. 22, 346 (2024).","journal-title":"Cell Commun. Signal."},{"key":"68031_CR64","doi-asserted-by":"publisher","first-page":"1223737","DOI":"10.3389\/fbioe.2023.1223737","volume":"11","author":"I Wilhelmsen","year":"2023","unstructured":"Wilhelmsen, I. et al. Characterization of human stem cell-derived hepatic stellate cells and liver sinusoidal endothelial cells during extended in vitro culture. Front. Bioeng. Biotechnol. 11, 1223737 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"68031_CR65","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2020.06.007","volume":"27","author":"BK Gage","year":"2020","unstructured":"Gage, B. K. et al. Generation of functional liver sinusoidal endothelial cells from human pluripotent stem-cell-derived venous angioblasts. Cell Stem Cell 27, 254\u2013269.e9 (2020).","journal-title":"Cell Stem Cell"},{"key":"68031_CR66","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/hepr.13893","volume":"53","author":"M Danoy","year":"2023","unstructured":"Danoy, M. et al. Transcriptomic and proteomic studies suggest the establishment of advanced zonation-like profiles in human-induced pluripotent stem cell-derived liver sinusoidal endothelial cells and carboxypeptidase M-positive liver progenitor cells cocultured in a fluidic microenvironment. Hepatol. Res. 53, 661\u2013674 (2023).","journal-title":"Hepatol. Res."},{"key":"68031_CR67","doi-asserted-by":"publisher","first-page":"015009","DOI":"10.1088\/1758-5090\/abbdb2","volume":"13","author":"B Lucendo-Villarin","year":"2020","unstructured":"Lucendo-Villarin, B. et al. Development of a cost-effective automated platform to produce human liver spheroids for basic and applied research. Biofabrication 13, 015009 (2020).","journal-title":"Biofabrication"},{"key":"68031_CR68","doi-asserted-by":"publisher","first-page":"2411667","DOI":"10.1002\/advs.202411667","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. hESCs-derived organoids achieve liver zonation features through LSEC modulation. Adv. Sci. 12, 2411667 (2025).","journal-title":"Adv. Sci."},{"key":"68031_CR69","doi-asserted-by":"crossref","unstructured":"Saiki, N. et al. Self-organization of sinusoidal vessels in pluripotent stem cell-derived human liver bud organoids. Nat. Biomed. Eng 9, 1869\u20131885 (2025).","DOI":"10.1038\/s41551-025-01416-6"},{"key":"68031_CR70","doi-asserted-by":"crossref","unstructured":"Van Riet, S., Julien, A., Atanasov, A., Nordling, \u00c5. & Ingelman-Sundberg, M. The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model. Hepatol. Commun. 8, e0374 (2024).","DOI":"10.1097\/HC9.0000000000000374"},{"key":"68031_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax5516","volume":"11","author":"K-J Jang","year":"2019","unstructured":"Jang, K.-J. et al. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci. Transl. Med. 11, eaax5516 (2019).","journal-title":"Sci. Transl. Med."},{"key":"68031_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96140-1","volume":"15","author":"Y Ueda","year":"2025","unstructured":"Ueda, Y., Omiya, S., Pinney, J., Bylicky, M. A. & Aryankalayil, M. J. Liver quad culture chip as a model for radiation injury research. Sci. Rep. 15, 12414 (2025).","journal-title":"Sci. Rep."},{"key":"68031_CR73","doi-asserted-by":"crossref","unstructured":"Bl\u00e9riot, C. & Ginhoux, F. Understanding the heterogeneity of resident liver macrophages. Front. Immunol. 10, 2694 (2019).","DOI":"10.3389\/fimmu.2019.02694"},{"key":"68031_CR74","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby, E., Chen, P. & Aouadi, M. Macrophage functional diversity in NAFLD \u2014 more than inflammation. Nat. Rev. Endocrinol. 18, 461\u2013472 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"68031_CR75","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1039\/C8LC00418H","volume":"18","author":"X Li","year":"2018","unstructured":"Li, X., George, S. M., Vernetti, L., Gough, A. H. & Taylor, D. L. A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME\/TOX. Lab. Chip 18, 2614\u20132631 (2018).","journal-title":"Lab. Chip"},{"key":"68031_CR76","doi-asserted-by":"publisher","unstructured":"Zhang, S. et al. ETV2 mediated differentiation of human pluripotent stem cells results in functional endothelial cells for engineering advanced vascularized microphysiological models. Preprint at https:\/\/doi.org\/10.1101\/2025.10.01.679558 (2025).","DOI":"10.1101\/2025.10.01.679558"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68031-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:03:23Z","timestamp":1770113003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68031"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68031-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.D.K is a co-founder of AIM Biotech, a company that markets microfluidic technologies. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"950"}}